CMT Capital Markets Trading’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-64,100
| Closed | -$1.71M | – | 411 |
|
|
2025
Q4 | $1.6M | Buy |
64,100
+50,300
| +364% | +$1.27M | 0.01% | 257 |
|
|
2025
Q3 | $352K | Sell |
13,800
-61,200
| -82% | -$1.51M | ﹤0.01% | 325 |
|
|
2025
Q2 | $1.82M | Buy |
75,000
+38,826
| +107% | +$905K | 0.02% | 210 |
|
|
2025
Q1 | $917K | Sell |
36,174
-55,926
| -61% | -$1.46M | 0.01% | 230 |
|
|
2024
Q4 | $2.44M | Sell |
92,100
-125,100
| -58% | -$3.39M | 0.03% | 199 |
|
|
2024
Q3 | $6.29M | Buy |
217,200
+205,200
| +1,710% | +$5.99M | 0.08% | 148 |
|
|
2024
Q2 | $336K | Sell |
12,000
-39,000
| -76% | -$1.07M | ﹤0.01% | 264 |
|
|
2024
Q1 | $1.42M | Buy |
51,000
+31,500
| +162% | +$874K | 0.02% | 203 |
|
|
2023
Q4 | $561K | Sell |
19,500
-5,800
| -23% | -$175K | 0.01% | 212 |
|
|
2023
Q3 | $839K | Buy |
25,300
+19,300
| +322% | +$682K | 0.01% | 212 |
|
|
2023
Q2 | $220K | Buy |
6,000
+200
| +3% | +$7.79K | ﹤0.01% | 242 |
|
|
2023
Q1 | $237K | Buy |
+5,800
| New | +$251K | ﹤0.01% | 218 |
|
|
2022
Q4 | – | Sell |
-33,500
| Closed | -$1.61M | – | 347 |
|
|
2022
Q3 | $1.47M | Buy |
+33,500
| New | +$1.63M | 0.01% | 236 |
|
|
2022
Q2 | – | Sell |
-35,000
| Closed | -$1.78M | – | 321 |
|
|
2022
Q1 | $1.81M | Sell |
35,000
-14,356
| -29% | -$745K | 0.01% | 227 |
|
|
2021
Q4 | $2.91M | Buy |
49,356
+26,376
| +115% | +$1.31M | 0.01% | 232 |
|
|
2021
Q3 | $1M | Buy |
22,980
+5,392
| +31% | +$239K | 0.01% | 270 |
|
|
2021
Q2 | $689K | Buy |
+17,588
| New | +$684K | 0.01% | 250 |
|
|
2021
Q1 | – | Sell |
-94,439
| Closed | -$3.35M | – | 291 |
|
|
2020
Q4 | $3.48M | Buy |
94,439
+79,186
| +519% | +$2.9M | 0.03% | 160 |
|
|
2020
Q3 | $473K | Hold |
15,253
| – | – | ﹤0.01% | 227 |
|
|
2020
Q2 | $473K | Sell |
15,253
-6,634
| -30% | -$225K | 0.01% | 223 |
|
|
2020
Q1 | $678K | Buy |
+21,887
| New | +$746K | 0.01% | 182 |
|
|
2019
Q4 | – | Sell |
-96,828
| Closed | -$3.45M | – | 216 |
|
|
2019
Q3 | $3.3M | Buy |
+96,828
| New | +$3.52M | 0.09% | 89 |
|
|
2019
Q1 | – | Sell |
-16,759
| Closed | -$671K | – | 145 |
|
|
2018
Q4 | $694K | Buy |
+16,759
| New | +$696K | 0.02% | 106 |
|
|
2018
Q3 | – | Sell |
-42,338
| Closed | -$1.63M | – | 154 |
|
|
2018
Q2 | $1.46M | Sell |
42,338
-59,900
| -59% | -$2.05M | 0.04% | 106 |
|
|
2018
Q1 | $3.44M | Buy |
+102,238
| New | +$3.51M | 0.09% | 86 |
|
|
2017
Q2 | – | Sell |
-39,055
| Closed | -$1.23M | – | 156 |
|
|
2017
Q1 | $1.27M | Buy |
39,055
+12,835
| +49% | +$405K | 0.13% | 91 |
|
|
2016
Q4 | $808K | Buy |
26,220
+4,869
| +23% | +$149K | 0.07% | 120 |
|
|
2016
Q3 | $686K | Buy |
+21,351
| New | +$714K | 0.07% | 119 |
|
|
2016
Q2 | – | Sell |
-35,062
| Closed | -$1.12M | – | 152 |
|
|
2016
Q1 | $986K | Buy |
35,062
+13,744
| +64% | +$393K | 0.14% | 87 |
|
|
2015
Q4 | $653K | Buy |
+21,318
| New | +$671K | 0.07% | 107 |
|
Other funds holding PFE
VCM
VPM
CMT Capital Markets Trading's PFE Position: Q1 2026 in Review
CMT Capital Markets Trading sold out of Pfizer (PFE) in Q1 2026, closing a stake of 64,100 shares — an estimated $1.71M sold.
CMT Capital Markets Trading first reported a position in PFE in Q4 2015 and held it in 30 quarters. The position peaked at $6.29M in Q3 2024. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- CMT Capital Markets Trading reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- CMT Capital Markets Trading sold 64,100 Pfizer shares in Q1 2026, an estimated $1.71M.
- CMT Capital Markets Trading first reported a position in Pfizer in Q4 2015 and held it in 30 quarters.
- CMT Capital Markets Trading's Pfizer position peaked at $6.29M in Q3 2024.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on CMT Capital Markets Trading's 13F filing for Q1 2026, filed 15 May 2026.